Probably due to decreased CXCL12 cleavage, DPP-IV ablation promoted epithelial–mesenchymal transition, breast cancer metastasis, and the upregulation of ABC transporters via the CXCL12/CXCR4/mTOR axis [80,81]. The gene discussed is FAP; the disease is breast carcinoma.